Thomas E. Hughes - Net Worth and Insider Trading
Thomas E. Hughes Net Worth
The estimated net worth of Thomas E. Hughes is at least $23,491 dollars as of 2024-04-19. Thomas E. Hughes is the Director of Viridian Therapeutics Inc and owns about 855 shares of Viridian Therapeutics Inc (VRDN) stock worth over $13,158. Thomas E. Hughes is also the See Remarks of Zafgen Inc and owns about 10,437 shares of Zafgen Inc (ZFGN) stock worth over $10,333. Details can be seen in Thomas E. Hughes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas E. Hughes has not made any transactions after 2018-10-11 and currently still holds the listed stock(s).
Transaction Summary of Thomas E. Hughes
Thomas E. Hughes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas E. Hughes owns 2 companies in total, including Viridian Therapeutics Inc (VRDN) , and Larimar Therapeutics Inc (LRMR) .
Click here to see the complete history of Thomas E. Hughes’s form 4 insider trades.
Insider Ownership Summary of Thomas E. Hughes
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VRDN | Viridian Therapeutics Inc | 2018-10-11 | director |
| LRMR | Larimar Therapeutics Inc | 2015-09-17 | director & Chief Executive Officer |
Thomas E. Hughes Latest Holdings Summary
Thomas E. Hughes currently owns a total of 2 stocks. Among these stocks, Thomas E. Hughes owns 855 shares of Viridian Therapeutics Inc (VRDN) as of October 11, 2018, with a value of $13,158 and a weighting of 56.01%. Thomas E. Hughes also owns 10,437 shares of Zafgen Inc (ZFGN) as of June 28, 2018, with a value of $10,333 and a weighting of 43.99%.
Latest Holdings of Thomas E. Hughes
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics Inc | 2018-10-11 | 855 | 15.39 | 13,158 |
| ZFGN | Zafgen Inc | 2018-06-28 | 10,437 | 0.99 | 10,333 |
Holding Weightings of Thomas E. Hughes
Thomas E. Hughes Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas E. Hughes has made a total of 0 transactions in Viridian Therapeutics Inc (VRDN) over the past 5 years. The most-recent trade in Viridian Therapeutics Inc is the acquisition of 667 shares on October 11, 2018, which cost Thomas E. Hughes around $47,700.
According to the SEC Form 4 filings, Thomas E. Hughes has made a total of 0 transactions in Zafgen Inc (ZFGN) over the past 5 years. The most-recent trade in Zafgen Inc is the sale of 2,667 shares on June 28, 2018, which brought Thomas E. Hughes around $320,000.
Insider Trading History of Thomas E. Hughes
- 1
Thomas E. Hughes Trading Performance
GuruFocus tracks the stock performance after each of Thomas E. Hughes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas E. Hughes is 2.03%. GuruFocus also compares Thomas E. Hughes's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas E. Hughes within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas E. Hughes's insider trading performs compared to the benchmark.
Performance of Thomas E. Hughes
Average Return
-15.15%
Outperforming Transactions
67%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.37 | 2.03 | 10.2 | -15.15 | 34.11 | -34.22 |
| Relative Return to S&P 500(%) | -0.68 | 3.79 | 3.47 | -26.74 | 20.09 | -46.99 |
Thomas E. Hughes Ownership Network
Ownership Network List of Thomas E. Hughes
Ownership Network Relation of Thomas E. Hughes
Thomas E. Hughes Owned Company Details
What does Viridian Therapeutics Inc do?
Who are the key executives at Viridian Therapeutics Inc?
Thomas E. Hughes is the director of Viridian Therapeutics Inc. Other key executives at Viridian Therapeutics Inc include director & other: See Remarks Fairmount Healthcare Fund Gp Llc , director & President and CEO Stephen F. Mahoney , and Chief Operating Officer Thomas W. Beetham .
Viridian Therapeutics Inc (VRDN) Insider Trades Summary
Over the past 18 months, Thomas E. Hughes made no insider transaction in Viridian Therapeutics Inc (VRDN). Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net sale of 89,514 shares made by Lara Meisner , a net sale of 100,000 shares made by Jonathan Violin , and a net sale of 89,000 shares made by Barrett Katz .
In summary, during the past 3 months, insiders sold 0 shares of Viridian Therapeutics Inc (VRDN) in total and bought 476,190 shares, with a net purchase of 476,190 shares. During the past 18 months, 278,514 shares of Viridian Therapeutics Inc (VRDN) were sold and 485,690 shares were bought by its insiders, resulting in a net purchase of 207,176 shares.
Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Viridian Therapeutics Inc Insider Transactions
Thomas E. Hughes Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas E. Hughes. You might contact Thomas E. Hughes via mailing address: C/o Zafgen, Inc., One Broadway, 8th Floor, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
